Developmental regulation of group i metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia

Neuron Glia Biology

Volumn 6, Issue 4, 2010, Pages 277-288

  Jantzie, Lauren L ^a   Talos, Delia M ^a   Selip, Debra B ^a   An, Li ^a   Jackson, Michele C ^a   Folkerth, Rebecca D ^b   Deng, Wenbin ^c   Jensen, Frances E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

(1S,3R) 1 aminocyclopentane trans 1,3, dicarboxylic acid (ACPD); excitotoxicity; Hypoxia ischemia (HI); metabotropic glutamate receptor (mGluR); oligodendrocyte (OL); periventricular leukomalacia (PVL)

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR AGONIST; MYELIN BASIC PROTEIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; BRAIN INJURY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENCEPHALOMALACIA; EXCITOTOXICITY; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VITRO STUDY; MALE; MICROGLIA; NERVE CELL; NERVE FIBER; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCHOOL CHILD; WHITE MATTER;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BRAIN; DIOXOLANES; DISEASE MODELS, ANIMAL; FETUS; GALACTOSYLCERAMIDASE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; LEUKOMALACIA, PERIVENTRICULAR; OLIGODENDROGLIA; PURINES; RATS; RATS, LONG-EVANS; RECEPTORS, METABOTROPIC GLUTAMATE;

RATTUS; RODENTIA;

EID: 84856988762     PISSN: 1740925X     EISSN: 17410533     Source Type: Journal    
DOI: 10.1017/S1740925X11000111     Document Type: Article

References (64)

1. Alexander G.M. and Godwin D.W. (2006) Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy. Epilepsy Research 71, 1-22. (Pubitemid 44233196)
2. Allin M., Walshe M., Fern A., Nosarti C., Cuddy M., Rifkin L. et al. (2008) Cognitive maturation in preterm and term born adolescents. Journal of Neurology, Neurosurgery, and Psychiatry 79, 381-386. (Pubitemid 351441490)
3. Back S.A., Luo N.L., Borenstein N.S., Levine J.M., Volpe J.J. and Kinney H.C. (2001) Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. Journal of Neuroscience 21, 1302-1312. (Pubitemid 32128775)
4. Back S.A., Riddle A. and McClure M.M. (2007) Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke 38, 724-730. (Pubitemid 46184249)
5. Bao W.L., Williams A.J., Faden A.I. and Tortella F.C. (2001) Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia. Brain Research 922, 173-179. (Pubitemid 34017477)
6. Bayless S. and Stevenson J. (2007) Executive functions in school-age children born very prematurely. Early Human Development 83, 247-254. (Pubitemid 46441710)
7. Bear M.F. (2005) Therapeutic implications of the mGluR theory of fragile X mental retardation. Genes, Brain and Behaviour 4, 393-398. (Pubitemid 41192450)
8. Benveniste H. (1991) The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovascular & Brain Metabolism Reviews 3, 213-245.
9. Biber K., Laurie D.J., Berthele A., Sommer B., Tolle T.R., Gebicke-Harter P.J. et al. (1999) Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia. Journal of Neurochemistry 72, 1671-1680. (Pubitemid 29140843)
10. Boer K., Encha-Razavi F., Sinico M. and Aronica E. (2010) Differential distribution of group I metabotropic glutamate receptors in developing human cortex. Brain Research 1324, 24-33.
11. Butt A.M. (2006) Neurotransmitter-mediated calcium signaling in oligodendrocyte physiology and pathology. Glia 54, 666-675. (Pubitemid 44629630)
12. Byrnes K.R., Loane D.J. and Faden A.I. (2009a) Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders. Neurotherapeutics 6, 94-107.
13. Byrnes K.R., Stoica B., Loane D.J., Riccio A., Davis M.I. and Faden A.I. (2009b) Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity. Glia 57, 550-560.
14. Carroll F.I. (2008) Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction. Annals of the New York Academy of Sciences 1141, 221-232.
15. Catania M.V., D'Antoni S., Bonaccorso C.M., Aronica E., Bear M.F. and Nicoletti F. (2007) Group I metabotropic glutamate receptors: a role in neurodevelopmental disorders? Molecular Neurobiology 35, 298-307. (Pubitemid 350129691)
16. Dean J.M., Moravec M.D., Grafe M., Abend N., Ren J., Gong X. et al. (2011) Strain-specific differences in perinatal rodent oligodendrocytes lineage progression and its correlation with human. Developmental Neuroscience, doi: 10.1159/000327242. Epub ahead of Print, August 24, 2011.
17. Deng W., Wang H., Rosenberg P.A., Volpe J.J. and Jensen F.E. (2004) Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proceedings of the National Academy of Sciences of the U.S.A. 101, 7751-7756. (Pubitemid 38658101)
18. D'Antoni S., Berretta A., Bonaccorso C.M., Bruno V., Aronica E., Nicoletti F. et al. (2008) Metabotropic glutamate receptors in glial cells. Neurochemistry Research 33, 2436-2443.
19. Di Giorgi Gerevini V.D., Caruso A., Cappuccio I., Ricci Vitiani L., Romeo S., Della Rocca C. et al. (2004) The mGlu5 metabotropic glutamate receptor is expressed in zones of active neurogenesis of the embryonic and postnatal brain. Brain Research. Developmental Brain Research 150, 17-22. (Pubitemid 39090079)
20. Drouin-Ouellet J., Bownell A.-L., Saint-Pierre M., Fasano C., Emond V., Trudeau L.-E. et al. (2011) Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions. Glia 59, 188-199.
21. Farso M.C., O'Shea R.D. and Beart P.M. (2009) Evidence group I mGluR drugs modulate the activation profile of lipopolysaccharideexposed microglia in culture. Neurochemical Research 34, 1721-1728.
22. Fern R. and Moller T. (2000) Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. Journal of Neuroscience 20, 34-42. (Pubitemid 30220488)
23. Ferraguti F. and Shigemoto R. (2006) Metabotropic glutamate receptors. Cell and Tissue Research 326, 483-504. (Pubitemid 44435821)
24. Ferriero D. (2004) Neonatal brain injury. New England Journal of Medicine 351, 1985-1995.
25. Folkerth R.D., Haynes R.L., Borenstein N.S., Belliveau R.A., Trachtenberg F., Rosenberg P.A. et al. (2004) Developmental lag in superoxide dismutases relative to other anti-oxidant enzymes in premyelinated human telencephalic white matter. Journal of Neuropathology and Experimental Neurology 63, 990-999. (Pubitemid 39202501)
26. Follett P.L., Deng W., Dai W., Talos D.M., Massillon L.J., Rosenberg P.A. et al. (2004) Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. Journal of Neuroscience 24, 4412-4420. (Pubitemid 38608152)
27. Follett P.L., Rosenberg P.A., Volpe J.J. and Jensen F.E. (2000) NBQX attenuates excitotoxic injury in developing white matter. Journal of Neuroscience 20, 9235-9241. (Pubitemid 32042926)
28. Gonsette R.E. (2008) Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? Multiple Sclerosis 14, 22-34. (Pubitemid 351541394)
29. Haynes R.L., Folkerth R.D., Keefe R.J., Sung I., Swzeda L.I., Rosenberg P.A. et al. (2003) Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. Journal of Neuropathology and Experimental Neurology 62, 441-450. (Pubitemid 36560186)
30. Hodge C.W., Miles M.F., Sharko A.C., Stevenson R.A., Hillmann J.R., Lepoutre V. et al. (2006) The mGluR antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-admnistration in C57BL/6J mice. Psychopharmacology 183, 429-438. (Pubitemid 41721144)
31. Jantzie L.L., Cheung P.Y. and Todd K.G. (2005) Doxycycline reduces cleaved caspase-3 and microglial activation in an animal model of neonatal hypoxia-ischemia. Journal of Cerebral Blood Flow Metabolism 25, 314-324. (Pubitemid 40315874)
32. Jantzie L.L. and Todd K.G. (2010) Doxycycline inhibits proinflammatory cytokines but not acute cerebral cytogenesis after hypoxia-ischemia in neonatal rats. Journal of Psychiatry and Neuroscience 35, 20-32.
33. Jensen F. (2006) Developmental factors regulating susceptibility to perinatal brain injury and seizures. Current Opinion in Pediatrics 18, 628-633. (Pubitemid 44747155)
34. Karadottir R. and Attwell D. (2007) Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience 145, 1426-1438. (Pubitemid 46602726)
35. Kelland E.E. and Toms N.J. (2001) Group I metabotropic glutamate receptors limit AMPA receptor-mediated oligodendrocyte progenitor cell death. European Journal of Pharmacology 424, R3-R4. (Pubitemid 32728313)
36. Kinney H.C. and Back S.A. (1998) Human oligodendroglial development: relationship to periventricular leukomalacia. Seminars in Pediatric Neurology 5, 180-189. (Pubitemid 28432523)
37. Kobaly K., Schluchter M., Minich N., Friedman H., Taylor H.G., Wilson-Costello D. et al. (2008) Outcomes of extremely low birth weight (,1 kg) and extremely low gestational age (,28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003. Pediatrics 121, 73-81.
38. Larroque B., Ancel P.Y., Marret S., Marchand L., Andre M., Arnaud C. et al. (2008) Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study. Lancet 371, 813-820. (Pubitemid 351330166)
39. Lechpammer M., Manning S.M., Samonte F., Nelligan J., Sabo E., Talos D.M. et al. (2008) Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leukcomalacia. Neuropathology and Applied Neurobiology 34, 379-393.
40. Liu C., Lin N., Wu B. and Qiu Y. (2009) Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury. Brain Research 1282, 173-182.
41. Lojkova D. and Mares P. (2005) Anticonvulsant action of an antagonist of metabotropic glutamate receptor mGluR5 MPEP in immature rats. Neuropharmacology 49, 219-229. (Pubitemid 41115908)
42. Lujan R., Roberts J.D., Shigemoto R., Ohishi H. and Somogyi P. (1997) Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1a, mGluR2, mGluR5, relative to neurotransmitter release sites. Journal of Chemical Neuroanatomy 13, 219-241. (Pubitemid 27499502)
43. Luscher C. and Huber K.M. (2010) Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron 65, 445-459.
44. Luyt K., Varadi A., Durant C.F. and Molnar E. (2006) Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis. Journal of Neurochemistry 99, 641-656. (Pubitemid 44477218)
45. Luyt K., Varadi A. and Molnar E. (2003) Functional metabotropic glutamate receptors are expressed in oligodendrocyte progenitor cells. Journal of Neurochemistry 84, 1452-1464. (Pubitemid 36343611)
46. Maiese K., Chong Z.Z. and Li F. (2005) Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors. Current Neurovascular Research 2, 425-446. (Pubitemid 41789608)
47. Manning S.M., Talos D.M., Zhou C., Selip D.B., Park H.K., Park C.J. et al. (2008) NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. Journal of Neuroscience 28, 6670-6678.
48. Martin J.A., Kung H.C., Mathews T.J., Hoyert D.L., Strobino D.M., Guyer B. et al. (2008) Annual summary of vital statistics: 2006. Pediatrics 121, 788-801.
49. McDonald J.W. and Johnston M.V. (1990) Physiological and pathological roles of excitatory amino acids during central nervous system development. Brain Research. Brain Research Reviews 15, 41-70. (Pubitemid 20158154)
50. McDonald J.W., Fix A.S., Tizzano J.P. and Schoepp D.D. (1993) Seizures and brain injury in neonatal rats induced by 1S,3R-ACPD, a metabotropic glutamate receptor agonist. Journal of Neuroscience 13, 4445-4455. (Pubitemid 23299964)
51. Olive M.F. (2009) Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Current Drug Abuse Reviews 2, 83-98.
52. Rakhade S.N., Zhou C., Aujla P.K., Fishman R., Sucher N.J. and Jensen F.E. (2008) Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures. Journal of Neuroscience 28, 7979-7990.
53. Ribeiro F.M., Paquet M., Cregan S.P. and Ferguson S.S. (2010) Group I metabotropic glutamate receptor signaling and its implication in neurological disease. CNS & Neurological Disorders-Drug Targets 9, 574-595.
54. Romano C., Sesma M.A., McDonald C.T., O'Malley K., Van Den Pol A.N. and Olney J.W. (1995) Distribution of metabotropic glutamate receptor mGluR immunoreactivity in rat brain. Journal of Comparative Neurology 355, 455-469.
55. Silbereis J.C., Huang E.J., Back S.A. and Rowitch D.H. (2010) Towards improved animal models of neonatal white matter injury associated with cerebral palsy. Disease Models & Mechanisms 3, 678-688.
56. Snyder E.M., Philpot B.D., Huber K.M., Dong X., Fallon J.R. and Bear M.F. (2001) Internalization of ionotropic glutamate receptors in response to mGluR activation. Nature Neuroscience 4, 1079-1085. (Pubitemid 34116552)
57. Talos D., Fishman R., Park H., Folkerth R., Follett P., Volpe J.J. et al. (2006a) Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole- proprionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex. Journal of Comparative Neurology 497, 42-61.
58. Talos D., Follett P., Folkerth R., Fishman R., Trachtenberg F., Volpe J.J. et al. (2006b) Developmental regulation of alpha-amino-3-hydroxy-5-methyl- 4-isoxazole-proprionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex. Journal of Comparative Neurology 497, 61-77. (Pubitemid 43844568)
59. Taylor D.L., Pirianov G., Holland S., McGinnity C.J., Norman A.L., Reali C. et al. (2010) Attenuation of proliferation in oligodendroctye precursor cells by activated microglia. Journal of Neuroscience Research 88, 1632-1644.
60. Ure J., Baudry M. and Perassolo M. (2006) Metabotropic glutamate receptors and epilepsy. Journal of the Neurological Sciences 247, 1-9. (Pubitemid 44131467)
61. Vannucci R.C. (2000) Hypoxic-ischemic encephalopathy. American Journal of Perinatology 17, 113-119.
62. Volpe J.J. (2009) Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurology 8, 110-124.
63. Wake H., Lee P.R. and Fields R.D. (2011) Control of local protein synthesis and initial events in myelination by action potentials. Science 333, 1647-1651.
64. Zhong J., Gerber G., Kojic L. and Randic M. (2000) Dual modulation of excitatory synaptic transmission by agonists at group I metabotropic glutamate receptors in the rat spinal dorsal horn. Brain Research 887, 359-377. (Pubitemid 32008059)